First Onglyza and Kombligyze XR Heart Failure MDL Filed
More than 40 plaintiffs claiming that Onglyza and Kombiglyze caused their heart failure through lawsuits filed in various districts across the United States, asked that their cases be consolidated into a single multidistrict litigation in California. This will be the first application for an MDL for those who had heart issues from using the medication.
Onglyza & Heart Failure
Studies show that those using Onglyza have a 35% increased risk of heart failure. This is 35 people out of every 1,000. Hundreds of thousands of US consumers use Onglyza every day. Ongoing litigation alleges that AstraZeneca likely knew Onglyza had the potential for heart failure as early as 2006. This is three years before the FDA approved the drug.
Heart failure is a potentially deadly condition. It arises when the heart does not pump blood thoroughly enough to satisfy the needs of the body. According to the Centers for Disease Control and Prevention, heart failure contributed to 1 in every 9 deaths in the U.S. Half of all people who develop heart failure will die within 5 years of the diagnosis, according to the CDC.
Our Litigation Experience
Saxagliptin medications like Onglyza and Kombligyze XR have hurt thousands of people. It is especially important that if Onglyza hurt you to contact a law firm. Your law firm should have experience and the resources to get you the compensation you deserve. The Michael Brady Lynch Firm is that firm. We have decades of experience in recovering millions of clients. This is why we have received a high degree of peer recognition and professional achievement, such as inclusion on numerous Plaintiff Steering Committees such as:
Plaintiff’s Steering Committee (“PSC”) of In re Pradaxa Products Liability Litigation MDL #2385, which resulted in a global settlement of claims in excess of $650 million.
Plaintiff’s Executive Committee (PEC) in California coordinated Pradaxa litigation JCCP 4863, ongoing litigation representing victims of Pradaxa uncontrollable bleeding events post-MDL settlement.
Plaintiff’s Leadership Committee (“PLC”) of In re Pradaxa Connecticut State Court Consolidated Proceeding, ongoing litigation representing victims of Pradaxa uncontrollable bleeding events post-MDL settlement.
Plaintiff’s Steering Committee (“PSC”) of In re Viagra Products Liability Litigation MDL #2691, representing victims of melanoma associated with the erectile dysfunction drug Viagra.
Bellwether Committee for In re Xarelto Products Liability Litigation MDL #2592, responsible for the analysis and selection of trial cases in the Xarelto MDL.
Speak to an Attorney Today
If Onglyza harmed you or a loved one, you need an attorney with experience helping people who have been harmed by pharmaceutical drugs. The attorneys at the Michael Brady Lynch Firm know what it takes to go up against drug manufacturers to get clients what they need.